Cuban Vaccine Developers Evaluate Protection Against Severe Forms of COVID

The Abdala coronavirus vaccine, which was developed at the Center for Genetic Engineering and Biotechnology (CIGB) in Cuba, has shown 100% effectiveness against death from COVID-19 , as well as a severe course of the disease, Cubadebate reports.

Such data were obtained by scientists according to the results of the third phase of testing. More than 48 thousand volunteers from 18 medical centers took part in it. The vaccine developed by CIGB is three-component.

Previously, it was announced that the effectiveness of the drug against the symptomatic manifestation of COVID-19 is 92.28%.

The Cuban regulator Center for State Control of Medicines, Equipment and Medical Devices (CECMED) on July 9 authorized the emergency use of the vaccine on the island.